Search
NeuroOne Medical Technologies Corp
NMTCAdd to Watchlist
3.000USD
-0.040-1.32%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
25.85MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-1.32%
5 Days
-8.26%
1 Month
-19.35%
6 Months
-34.04%
Year to Date
-34.04%
1 Year
+328.57%
Key Figures
3.050Open
3.138High
19.01KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.22%Turnover Ratio
3.040Prev. Close
2.920Low
43.79KTurnover
LossP/E Static
4.81P/B
0.00%Div Yield TTM
-107.84%ROA
6.96052wk High
0.48Volume Ratio
-12.32MNet Profit
8.62MShares
-2.9507EPS TTM
0.53Beta
-204.44%ROE
3.27452wk Low
7.16%Amplitude
53.81%Gross Margin
25.85MMarket Cap
-3.21Reward/Risk
4.55%Risk Rate
TradingKey Stock Score of NeuroOne Medical Technologies Corp
Currency: USD Updated: 2026-06-30Key Insights
NeuroOne Medical Technologies Corp's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 106 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.93.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
NeuroOne Medical Technologies Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
NeuroOne Medical Technologies Corp Highlights
StrengthsRisks
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 250.82% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 12.10M.
Overvalued
The company’s latest PE is -1.03, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.36M shares, decreasing 8.88% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
9.933
Target Price
+226.75%
Upside Space
NeuroOne Medical Technologies Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
NeuroOne Medical Technologies Corp Info
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Ticker SymbolNMTC
CompanyNeuroOne Medical Technologies Corp
CEORosa (David A)
Websitehttps://nmtc1.com/
Related Instruments
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%
+0.78%Popular Instruments
FAQs
What is the current price of NeuroOne Medical Technologies Corp (NMTC)?
The current price of NeuroOne Medical Technologies Corp (NMTC) is 3.00.
What is the symbol of NeuroOne Medical Technologies Corp?
The ticker symbol of NeuroOne Medical Technologies Corp is NMTC.
What is the 52-week high of NeuroOne Medical Technologies Corp?
The 52-week high of NeuroOne Medical Technologies Corp is 6.96.
What is the 52-week low of NeuroOne Medical Technologies Corp?
The 52-week low of NeuroOne Medical Technologies Corp is 3.27.
What is the market capitalization of NeuroOne Medical Technologies Corp?
The market capitalization of NeuroOne Medical Technologies Corp is 25.85M.
Is NeuroOne Medical Technologies Corp (NMTC) currently rated as Buy, Hold, or Sell?
According to analysts, NeuroOne Medical Technologies Corp (NMTC) has an overall rating of Buy, with a price target of 9.93.
What is the Earnings Per Share (EPS TTM) of NeuroOne Medical Technologies Corp (NMTC)?
The Earnings Per Share (EPS TTM) of NeuroOne Medical Technologies Corp (NMTC) is -0.54.